Download PDF
Thromb Haemost 1989; 62(04): 1149-1150
DOI: 10.1055/s-0038-1647136
Letter to the Editor
Schattauer GmbH Stuttgart

Evaluation of D-Dimer in Patients with Liver Cirrhosis

E Violi
,
D Ferro
,
M Saliola
,
C Quintarelli
,
C Alessandri
Further Information

Publication History

Received 19 June 1989

Accepted after revision 26 September 1989

Publication Date:
24 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Cordova C, Violi F, Alessandri C, Ferro D, Saliola M, Musca A, Balsano F. Prekallikrein and factor VII as prognostic indexes of liver failure. Am J Clin Pathol 1986; 85: 579-582
    CrossrefPubMedGoogle Scholar
  • 2 Marongiu F, Mameli G, Acea MR, Mamusa AM, Mulas G, Balestrieri A. Low grade DIC in liver cirrhosis: fact or fiction. Thromb Haemostas 1988; 59 (02) 344
    PubMedGoogle Scholar
  • 3 Mombelli G, Monotti R, Haeberli A, Straub PW. Low grade DIC in liver cirrhosis: fact or fiction-Rebuttal. Thromb Haemostas 1988; 59 (02) 345
    PubMedGoogle Scholar
  • 4 Cordova C, Violi F, Alessandri C, Musca A, Balsano F. Low doses of calcium-heparin in liver cirrhosis. Thromb Haemostas 1985; 54 (02) 551
    PubMedGoogle Scholar
  • 5 Mannucci PM, Mari D. Hemostasis and liver disease. Haematologica 1981; 66 (02) 233-248
    PubMedGoogle Scholar
  • 6 Morgan D, Edward RL, Rickles FR. Monocyte procoagulant activity as a peripheral marker of clotting activation in cancer patients. Hemostasis 1988; 18: 55-56
    PubMedGoogle Scholar
  • 7 Coccheri G, Mannucci PM, Palareti G, Gervasoni W, Poggi M, ViganÒ S. Significance of plasma fibrinopeptide A and high molecular weight fibrinogen in patients with liver cirrhosis. Br J Haematol 1982; 52: 503-509
    CrossrefPubMedGoogle Scholar
  • 8 Mombelli G, Monotti R, Haeberli A, Straub PW. Relationship between fibrinopeptide A and fibrinogen/fibrin fragment E in thromboetnbolism, DIC and various non-thromboembolic diseases. Thromb Haemostas 1987; 58: 758-763
    PubMedGoogle Scholar
  • 9 Violi F, Alessandri C, Ferro D, Gallina G, Iuliano L, Balsano F. Fibrinopeptide A behaviour in chronic active hepatitis patients. Hematologica 1984; 69: 665-670
    PubMedGoogle Scholar
  • 10 Violi F, Alessandri C, Iuliano L, Frattaroli S, Gallina G, Balsano F. Behaviour of FDP, plasminogen and alpha-2-antiplasmin in chronic active hepatitis and liver cirrhosis patients showing high FpA values. Haemostasis 1984; 1: 109
    PubMedGoogle Scholar
  • 11 Eisenberg PR, Sherman LA, Perez J, Jaffe AS. Relationship between elevated plasma levels of crosslinked fibrin degradation products (XL-FDP) and the clinical presentation of patients with myocardial infarction. Thromb Res 1987; 46: 109-120
    CrossrefPubMedGoogle Scholar
  • 12 Bertaglia E, Belmonte P, Vertolli V, Azzurro M, Martines D. Bleeding in cirrhotic patients: a precipitating factor due to intravascular coagulation or to hepatic failure. Haemostasis 1983; 13: 328-335
    PubMedGoogle Scholar
  • 13 Francis BBjr, Feinstein DI. Clinical significance of accelerated fibrinolysis in liver diseases. Haemostasis 1984; 14: 460-466
    PubMedGoogle Scholar